Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cempra Inc (CEMP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 199,082
  • Shares Outstanding, K 52,390
  • Annual Sales, $ 18,020 K
  • Annual Income, $ -117,960 K
  • 36-Month Beta 0.97
  • Price/Sales 11.05
  • Price/Cash Flow 0.00
  • Price/Book 1.09

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.60 +6.94%
on 04/18/17
4.50 -14.44%
on 03/27/17
-0.25 (-6.10%)
since 03/24/17
3-Month
2.90 +32.76%
on 02/08/17
4.75 -18.95%
on 02/24/17
+0.70 (+22.22%)
since 01/26/17
52-Week
2.55 +50.98%
on 12/29/16
26.95 -85.71%
on 09/28/16
-14.31 (-78.80%)
since 04/26/16

Most Recent Stories

More News
Cempra Presents Data at ECCMID Highlighting Need for New CABP Therapies and Activity of Solithromycin in Key Population Groups

Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced the...

CEMP : 3.85 (+1.32%)
Cempra to Report First Quarter 2017 Financial Results

Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for acute care and community settings to meet critical medical needs in the treatment...

CEMP : 3.85 (+1.32%)
Cempra Withdraws Solithromycin Marketing Authorization Application in Europe

Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for the acute care and community settings to meet critical medical needs in the...

CEMP : 3.85 (+1.32%)
Mobileye and Cempra climb; Del Taco and Frontier dip

NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday:

TCBI : 79.10 (+2.33%)
FTR : 1.95 (-0.51%)
MBLY : 61.81 (-0.16%)
CHK : 5.60 (+1.63%)
AMD : 13.40 (-0.67%)
CEMP : 3.85 (+1.32%)
SYMC : 31.25 (-0.18%)
TACO : 13.26 (-0.75%)
Cempra Retains Morgan Stanley to Lead Review of Strategic Business Options

Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for the acute care and community settings to meet critical medical needs in the...

MS : 44.60 (+0.75%)
CEMP : 3.85 (+1.32%)
Dow Hits Record Close for 11th Consecutive Session: Today's Research Reports on Cempra and Universal Display

NEW YORK, NY / ACCESSWIRE / February 27, 2017 / The Dow Jones Industrial Average continued its streak of 11 consecutive record closes with a late-day rally Friday. The Dow fell by as much as 76 points,...

OLED : 88.65 (+0.23%)
CEMP : 3.85 (+1.32%)
Cempra to Report Fourth Quarter and Full Year 2016 Financial Results

Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced that...

CEMP : 3.85 (+1.32%)
CORRECTING and REPLACING -- Cempra to Present at Upcoming Investor Conferences

In a release issued under the same headline earlier today by Cempra, Inc. (Nasdaq:CEMP), the Leerink Partners conference should be noted as located at the Lotte New York Palace, not at the Waldorf Astoria...

CEMP : 3.85 (+1.32%)
Becton, Dickinson (BDX) Q1 Earnings: What's in the Cards?

Becton, Dickinson and Company (BDX) is set to report first-quarter fiscal 2017 earnings results on Feb 2.

UHS : 121.16 (-0.21%)
MOH : 49.82 (+1.30%)
BDX : 179.10 (+0.02%)
CEMP : 3.85 (+1.32%)
Will PerkinElmer (PKI) Disappoint this Earnings Season?

PerkinElmer Inc. (PKI) is expected to report fourth-quarter 2016 results on Feb 2, 2017.

UHS : 121.16 (-0.21%)
MOH : 49.82 (+1.30%)
CEMP : 3.85 (+1.32%)
PKI : 59.61 (+1.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Cempra Holdings, LLC is a pharmaceutical company engaged in developing antibiotics for the treatment of bacterial infectious diseases. It focuses on developing antibiotics for treating respiratory tract, skin and skin structure infections and to target the growing problem of antimicrobial resistance....

See More

Support & Resistance

2nd Resistance Point 3.93
1st Resistance Point 3.87
Last Price 3.85
1st Support Level 3.77
2nd Support Level 3.73

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.